Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone versus dexmedetomidine versus their combination for prevention of nausea and vomiting after laparoscopic cholecystectomy
IRCT20141209020258N100Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Dexmedetomidine, Dexamethasone and Dexmedetomidine + dexamethasone (3 arms). Primary endpoints: nausea and vomiting. Started Feb 2019; status: completed.
02
Drugs
dexamethasonedexmedetomidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20141209020258N100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N100.